Dr. Margolis Featured in New Yorker Article on HIV Cure

Dr David MargolisThe New Yorker recently featured the research of UNC School of Medicine researcher David Margolis, MD, in this article about the search for a cure to HIV infection.

Margolis, a professor of medicine, epidemiology, and microbiology and immunology, serves as director of the School of Medicine’s Program in Translational Clinical Research.

Dr. Margolis currently leads the largest collaboration of HIV researchers, working to force HIV out of “latency” so they can attempt to kill virus particles that typically lay dormant, hidden from therapies. Margolis was among the first researchers to explore methods to force HIV particles out of latency, which is considered a major obstacle to finding curative therapies.

Read the full story here.

UNC CFAR Investigators Featured at CROI 2015

CROI 2015Five abstracts from UNC CFAR have been accepted for presentation at the poster session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, each of which were supported by the UNC CFAR’s Biostatistics Core. This annual collaborative science conference brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2015 will be held from February 23 to February 26, 2015, in Seattle, Washington, at the Washington State Convention Center. Congratulations to all our CFAR investigators for their hard work and dedication!

Poster presentations that will feature UNC CFAR investigators at the conference this year:

Davis N, Miller W, Hudgens M, Chasela C, Sichali D, Nelson J, Rigdon J, Ellington S, Kourtis A, and van der Horst C. ARV adherence associated with reduced breastmilk HIV viral load and HIV transmission. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Jensen K, Van Rompay K, Jacobs W, Fennelly G, Mollan K, Hudgens M, Piatak M, Larsen M, De Paris K. The potential of BCG and HIV-TB vaccines to exacerbate HIV-1 pathogenesis in infants. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Joseph S, Kincer L, Bowman N, Menezes P, Robertson K, Anderson A, Loring D, Eron J, Price R, Swanstrom R. HIV-1 Replication in the CNS is Associated With Increased Neurocognitive Impairment. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

King C, Nelson J, Ziemniak C, Hudgens M, Tegha G, Chasela C, Jamieson D, Persaud D, van der Horst C, Kourtis A. Delayed HIV Detection in Infants Exposed to ARV Prophylaxis During Breastfeeding. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Nelson J, Fokar A, Hudgens M, Compliment K, Tegha G, Kamwendo D, Kourtis A, Jamieson D, van der Horst C, Fiscus S. NVP Resistance in Infants Infected by HIV-1 via Breastfeeding in the BAN Study. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

NC TraCS Institute Research Open House

open houseJoin the NC TraCS Institute for their Open House, filled with presentations on issues, resources, and services related to research.

October 1, 2014
10:00 AM – 5:00 PM
2nd floor of the Brinkhous-Bullitt Building
UNC-Chapel Hill Campus

Presentations will explore:

• Innovation in health data dissemination
• Research and Latino populations
• Community engagement in research and Community Advisory Boards
• Comparative Effectiveness Research
• Promoting entrepreneurship through academic corporate partnerships

CAARE, Inc’s Executive Director, Dr. Sharon Elliott-Bynum, will present “Nothing About Us Without Us- Community Engagement in Research” from 1:30-2:00pm in room 226.

See the full schedule here.

Friday ID Conference: Acceptability of Male Circumcision for HIV Prevention in the Dominican Republic

BritoThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“The Acceptability of Male Circumcision for HIV Prevention in the Dominican Republic”
Max Brito, MD, MPH
University of Illinois at Chicago

September 26, 2014
8:30 – 9:30 a.m.
1131 Bioinformatics
UNC Campus (directions)

Max Brito, MD, MPH is an Associate Professor and Vice Chair for Urban Global Health in the Department of Medicine at the University of Illinois at Chicago. His clinical research focuses on HIV prevention in the Caribbean. He specializes in the treatment of patients co-infected with the HIV and hepatitis viruses.

Dr. Brito’s main areas of interest are International health, HIV co-infections and medical education. He serves as the coordinator of the Dominican Republic Project, an educational exchange program with the aim of promoting scientific collaborations with colleagues in that country and in the rest of Latin America. He also has a clinical interest in the care of patients co-infected with the HIV and HCV/HBV viruses and the impact of that epidemic in the US Hispanic population. He is also interested in medical education, particularly in studying effective methods to teach US medical trainees in international settings. Dr. Brito is currently the Program Director for the University of Illinois ID fellowship program; he trained in Internal Medicine at Mount Sinai Medical Center and completed an Infectious Diseases fellowship at the University of Miami, School of Medicine.

Refreshments will be served.

Friday ID Conference: Progress and Challenges in STI Research

King HolmesThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“Progress and Challenges in STI Research”
King Holmes, MD, PhD, FIDSA
Department of Global Health at University of Washington

September 19, 2014
8:30 – 9:30 a.m.
4th Floor Old Clinic, UNC-CH Campus

King K. Holmes MD, PhD, FIDSA, has dedicated 50 years to research on the epidemiology, diagnosis, and treatment and prevention of sexually transmitted infections. From 2006-2014, Dr. Holmes served as the first William H. Foege Chair of the Department of Global Health at the University of Washington, where he is Professor of Global Health and Medicine, and Adjunct Professor of Microbiology and Epidemiology. He also heads the Infectious Diseases Section at Harborview Medical Center. He founded and directs the UW Center for AIDS and STD, a WHO Collaborating Center.

Refreshments will be served.

Combination Therapy in HIV Cure Research Conference

Dr David MargolisThe Collaboratory of AIDS Researchers for Eradication (CARE) is hosting a community presentation:

Combination Therapy in HIV Cure Research
Monday, September 15, 2014
11 am – 12 pm EDT | 8 – 9 am PDT

Speaker: David M. Margolis, MD, FACP
Professor of Medicine, Microbiology and Immunology, Epidemiology
Principal Investigator, Collaboratory of AIDS Researchers for Eradication (CARE)
The University of North Carolina at Chapel Hill (UNC-CH)
Institute for Global Health and Infectious Diseases (IGHID)

To join the online meeting:

1. Go to this website.
2. If requested, enter your name and email address.
3. If a password is required, enter the meeting password: care2cure
4. Click “Join”.

To join the audio conference through telephone:

US TOLL FREE: +1-855-282-6330
US TOLL: +1-415-655-0003

Time: 10:45 am, Eastern Daylight Time
Meeting Number: 734-892-997
Meeting Password: care2cure

For assistance, visit this website. On the left navigation bar, click “Support”.

New book: Innovations in HIV Prevention Research and Practice through Community Engagement

Innovations in HIV ResearchUNC CFAR investigator Scott Rhodes, PhD, MPH, from the Wake Forest School of Medicine has edited a new book: Innovations in HIV Prevention Research and Practice through Community Engagement.

Leaders in the field who are working at various points along the community-engagement continuum, with diverse populations, and different types of HIV prevention interventions (e.g., individual, community, and structural) have contributed important chapters that outline both innovative interventions designed to reduce HIV risk among some of the most affected communities and authentic and meaningful approaches to engagement, partnership, and CBPR. Chapter authors include community members who may come from communities greatly affected by HIV in the United States; organization representatives who are providing services to members of these communities; business representatives; federal scientists and practitioners; and academic researchers who must negotiate the challenges of their institutions (e.g., tenure and funding) and federal and foundation funders who may not understand the challenges and potential successes associated with authentic engagement, partnership, and CBPR.

Information can be found at Springer and at Amazon.